Pregnancy Hypertension-An International Journal of Womens Cardiovascul

Papers
(The H4-Index of Pregnancy Hypertension-An International Journal of Womens Cardiovascul is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Comparison of subfoveal choroidal thickness in patients with hypertensive disorder of pregnancy versus normotensive pregnant women in third trimester of pregnancy37
GSTP1-A313G genetic polymorphism and the risk of preeclampsia in pregnant women: A study in the northern population of Iran28
Sociodemographic risk factors associated with patient follow-up after implementation of a CardioObstetrics program26
Six-week blood pressure trends in postpartum patients utilizing remote patient monitoring program26
PO1_20. Midtrimester drop in bp is not associated with a decreased risk for hypertensive disorder of pregnancy in a nulliparous cohort25
PO8_1. CANCELLED : Predictive value of longitudinal maternal serum angiogenic marker assessment for maternal adverse outcomes in pregnancies with preeclampsia25
PO6_15. Predictive utility for preeclampsia of the SFLT-1/PLGF ratio test in routine clinical practice: a retrospective analysis of 1,397 pregnancies with suspected pre-eclampsia22
OP15_4. A biopolymer-fused form of placental growth factor for treatment of preeclampsia19
OP14_5. Metformin to prolong pregnancy in preterm preeclampsia19
PO6_19. The diagnostic accuracy of American college of cardiology/American heart association blood pressure categories for identification of women and babies at risk of adverse pregnancy outcomes – a 18
Fetal growth and Doppler abnormalities associated with antenatal bisoprolol exposure17
Efficacy of B7-33 peptide in attenuating preeclampsia symptoms in rat models17
Perceptions and experiences of blood pressure self-monitoring during hypertensive pregnancy: A qualitative analysis of women’s and clinicians’ experiences in the OPTIMUM-BP trial17
Implementation and uptake of calcium and aspirin for prevention of preeclampsia in Malawi; Post trial views and recommendations of health care workers16
Cardiometabolic health 8–12 years after pre-eclampsia: Role of obesity and gestational diabetes (FINNCARE study)14
Comparison of Zuspan regimen and its 12-hour modification in women with severe pre-eclampsia and eclampsia in two hospitals in Abeokuta14
Examining changes in clinical management and postpartum readmissions for hypertensive disorders of pregnancy over time14
New 3D cardiac in vitro models for assessing the maternal cardiovascular health five years post hypertensive disorders of pregnancy14
0.28980708122253